Lv31
396 积分 2024-03-29 加入
Risovalisib for PIK3CA-mutated recurrent or persistent ovarian clear cell carcinoma: a single-arm, multicentre, phase 2 trial
13小时前
求助中
Alpelisib in pediatric PIK3CA- and TIE-2–mutant vascular anomalies: a case series on safety, efficacy, and drug exposure
2个月前
已完结
Alpelisib for the treatment of PIK3CA-related head and neck lymphatic malformations and overgrowth
2个月前
已完结
Activity and safety of atezolizumab plus carboplatin and paclitaxel in patients with advanced or recurrent thymic carcinoma (MARBLE): a multicentre, single-arm, phase 2 trial
2个月前
已完结
钠-葡萄糖共转运蛋白2抑制剂联合胰岛素治疗2型糖尿病中国专家共识
2个月前
已完结
Nivolumab and Ipilimumab Combination Treatment in Advanced Ovarian and Endometrial Clear Cell Cancers
6个月前
已完结
Benmelstobart plus anlotinib versus pembrolizumab as first-line treatment for PD-L1-positive, advanced non-small-cell lung cancer (CAMPASS): a blinded, randomised, controlled, phase 3 trial
6个月前
已完结
Heart failure in children
6个月前
已关闭
皖公网安备34019202002308
